Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Schwetz, V; Eisner, F; Schilcher, G; Eller, K; Plank, J; Lind, A; Pieber, TR; Mader, JK; Eller, P.
Combined metformin-associated lactic acidosis and euglycemic ketoacidosis.
Wien Klin Wochenschr. 2017; 129(17-18):646-649
Doi: 10.1007/s00508-017-1251-6
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Mader Julia
-
Theiler-Schwetz Verena
- Co-authors Med Uni Graz
-
Eisner Florian
-
Eller Kathrin
-
Eller Philipp
-
Lind Alice Florentina
-
Pieber Thomas
-
Schilcher Gernot
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: In renal failure metformin can lead to lactic acidosis. Additional inhibition of hepatic gluconeogenesis by accumulation of the drug may aggravate fasting-induced ketoacidosis. We report the occurrence of metformin-associated lactic acidosis (MALA) with concurrent euglycemic ketoacidosis (MALKA) in three patients with renal failure. CASE PRESENTATIONS: Patient 1: a 78-year-old woman (pH = 6.89, lactic acid 22 mmol/l, serum ketoacids 7.4 mmol/l and blood glucose 63 mg/dl) on metformin and insulin treatment. Patient 2: a 79-year-old woman on metformin treatment (pH = 6.80, lactic acid 14.7 mmol/l, serum ketoacids 6.4 mmol/l and blood glucose 76 mg/dl). Patient 3: a 71-year-old man on metformin, canagliflozin and liraglutide treatment (pH = 7.21, lactic acid 5.9 mmol/l, serum ketoacids 16 mmol/l and blood glucose 150 mg/dl). In all patients, ketoacidosis receded on glucose infusion and renal replacement therapy. CONCLUSION: This case series highlights the parallel occurrence of MALA and euglycemic ketoacidosis, the latter exceeding ketosis due to starvation, suggesting a metformin-triggered inhibition of gluconeogenesis. Affected patients benefit from glucose infusion counteracting suppressed hepatic gluconeogenesis.
- Find related publications in this database (using NLM MeSH Indexing)
-
Acidosis, Lactic - chemically induced
-
Aged - administration & dosage
-
Blood Glucose - metabolism
-
Canagliflozin - adverse effects, therapeutic use
-
Diabetes Mellitus, Type 2 - blood, drug therapy
-
Drug Therapy, Combination - administration & dosage
-
Female - administration & dosage
-
Gluconeogenesis - drug effects
-
Humans - administration & dosage
-
Insulin - adverse effects, therapeutic use
-
Ketosis - chemically induced
-
Kidney Failure, Chronic - complications
-
Liraglutide - adverse effects, therapeutic use
-
Male - administration & dosage
-
Metformin - adverse effects, therapeutic use
- Find related publications in this database (Keywords)
-
Ketoacidosis
-
Type 2 diabetes
-
Metformin
-
Lactic acidosis